Skip to main content

Advertisement

Table 1 Association between INAVA expression and clinicopathologic parameters in PTC patients using TCGA dataset

From: INAVA promotes aggressiveness of papillary thyroid cancer by upregulating MMP9 expression

Clinicopathologic variables (n) INAVA P value
Low High
Age (years)
 < 45 (331) 156 175 0.070
 ≥ 45 (165) 92 73  
Gender
 Male (131) 62 69 0.476
 Female (365) 186 179  
TNM stage
 I and II (329) 178 151 0.010
 III and IV (165) 69 96  
 Unknown (2)    
T classification
 T1 and T2 (307) 167 140 0.017
 T3 and T4 (187) 81 106  
 Unknown (2)    
Lymph node metastasis
 No (227) 135 92 < 0.001
 Yes (219) 83 136  
 Unknown (50)